038460 — BioSmart Co Income Statement

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMicro CapContrarian

Annual income statement for BioSmart Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	189,183	391,822	456,164	484,310	482,776
Cost of Revenue
Gross Profit	68,436	76,729	79,006	82,262	85,256
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	179,252	382,132	433,729	470,622	459,489
Operating Profit	9,931	9,690	22,436	13,687	23,287
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,341	1,956	21,178	7,061	14,724
Provision for Income Taxes
Net Income After Taxes	634	-1,182	16,179	1,055	8,986
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,392	721	17,907	127	9,009
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,392	721	17,907	127	9,009
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	19.8	48.3	473	202	332
Dividends per Share